Navigation Links
Osteoporosis Meds and Jaw Pain: What's the Risk?

Reports of osteoporosis drugs causing jaw problems have you wondering: Should you stop taking them? //

It's true that there have been reports of partial death of a jawbone (osteonecrosis) related to osteoporosis medications, but the risk is very small, according to the December issue of Mayo Clinic Health Letter.

In contrast, the health risks associated with osteoporosis — a disease that causes bones to become brittle and to fracture — are high. More than half of Americans over 50 either have or are at risk of developing osteoporosis. If a fracture occurs, you're at risk of becoming disabled, ending up in a nursing home or even dying.

To treat osteoporosis, millions of Americans take oral bisphosphonate drugs, a class of drugs that includes alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel) and others. Estimates indicate about 20 cases of osteonecrosis may occur in a year in this large group of people. Osteonecrosis is characterized by jaw pain, swelling, loose teeth and exposed jawbone.

It's not fully known how oral bisphosphonates are associated with osteonecrosis or why it occurs in the jaw. Most cases have occurred after tooth removal or oral surgery. The risk of osteonecrosis appears to be higher for people who take the drug intravenously, which is a treatment for some cancers.

If you take oral bisphosphonate drugs, you may be able to lower your already low risk of developing osteonecrosis by practicing good hygiene and visiting your dentist for regular checkups. If possible, consider having major dental work done before starting the medication. If you take the medication, talk to your dentist and doctor about whether taking a break from the medication might be appropriate before dental work.

Source-Newswise
SR
'"/>




Page: 1

Related medicine news :

1. New treatment for Osteoporosis
2. Osteoporosis in men
3. Osteoporosis Drugs: right time to take-off
4. Fluoride Found Effective in Osteoporosis
5. Mutation connected to Osteoporosis
6. Osteoporosis associated with Childhood Cancer
7. A treatment for Osteoporosis
8. Osteoporosis could be caused by irregular periods
9. Back exercises reduces Osteoporosis
10. Osteoporosis and kidney stones gene marker identified
11. The Answer To Prevent Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... 2016 , ... "FCPX Overlay Glare is a tool that utilizes light found ... or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. , ... lights that simulates the look of a glare. Just drag and drop to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... been featured in SuperbCrew magazine, a leading online tech news platform connecting technology ... now featured on SuperbCrew.com, explores the state of enterprise mobility security today, and ...
(Date:12/5/2016)... ... , ... “Epilepsy Awareness,” which can be found at the ... about epilepsy, bearing down on the social stigma and lack of public education ... within their lifetime. With such a large percentage of people affected, it’s critically ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders are equal ... Castlewood Treatment Centers has always been to promote the power of recovery, and ... possible. In that spirit, Castlewood has announced two new hires, both Outreach Directors ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology: